Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

16.66 -0.11 (-0.66%)
Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
News headline image
Why Tylenol Maker Kenvue Stock Just Popped ↗
Kenvue's value isn't obvious -- but a merged Kenvue and Kimberly-Clark might be a buy. 
Via The Motley Fool
Topics Government
News headline image
Dow Jones Extends Gains as Palantir Eyes AI-Driven Surge and Kenvue Soars on Kimberly-Clark Takeover
New York, NY – November 3, 2025 – The Dow Jones Industrial Average is on track to extend its robust gains as the market closes out a strong trading day, buoyed by a confluence of positive factors... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Discover the top S&P500 movers in Monday's pre-market session. ↗
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. 
Via Chartmill
News headline image
Looking Into Kenvue Inc's Recent Short Interest ↗
 
Via Benzinga
News headline image
KVUE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Kenvue Inc. is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On? ↗
Shares of Kimberly-Clark Corporation (NASDAQ: KMB) plunged 16.49% during the pre-market trading session on Monday, after it announced the acquisition of Kenvue Inc. (NYSE: KVUE). 
Via Benzinga
News headline image
Kenvue Shares Soar 20% Pre-market After Inking $48.7B Deal With Kimberly-Clark ↗
Upon closing, Kimberly-Clark shareholders are expected to own approximately 54% and current Kenvue shareholders are expected to own approximately 46% of the combined company. 
Via Stocktwits
News headline image
Kenvue Reports Third Quarter 2025 Results
From Kenvue
Via Business Wire
News headline image
Will President Trump's Tylenol Claims Hurt These 2 Leading Pharmaceutical Stocks? ↗
Even though Kenvue's stock was already in a tailspin before the FDA warned pregnant woman that Tylenol posed a health risk, there are still some lingering impacts to consider. 
Via The Motley Fool
Topics Government
News headline image
Should You Buy Shares in the Super-Safe Dividend King Stock That Expects to Return $10 Billion to Shareholders in Its Fiscal 2026? ↗
P&G is one of the best dividend stocks for risk-averse investors to buy now and hold for years to come. 
Via The Motley Fool
Topics Economy
News headline image
These 3 Dividend Stocks Yield More Than 5% and Have Payout Ratios Over 100%. Are Dividend Cuts Coming? ↗
A high payout ratio can be concerning, but that doesn't always mean the dividend in question is destined to be cut. 
Via The Motley Fool
Topics Government
News headline image
Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations ↗
Via MarketBeat
News headline image
What's going on in today's session: S&P500 most active stocks ↗
Looking for the most active stocks in the S&P500 index on Wednesday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market. 
Via Chartmill
News headline image
Nvidia To Rally Around 37%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
This Stride Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗
 
Via Benzinga
News headline image
Kenvue Declares Quarterly Cash Dividend
From Kenvue
Via Business Wire
News headline image
Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety ↗
Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women. 
Via Benzinga
Topics Lawsuit
News headline image
Kenvue Stock Drops After Texas Attorney General Sues Company Alleging Deceptive Marketing Of Tylenol ↗
The lawsuit comes on the heels of President Trump linking Tylenol to autism. 
Via Stocktwits
Topics Government Lawsuit
News headline image
Renaissance Capital Opens New Circle Internet Group (NASDAQ: CRCL) Position: Is the New IPO a Buy? ↗
Renaissance Capital Opens New Circle Internet Group (NASDAQ: CRCL) Position: Is the New IPO a Buy? 
Via The Motley Fool
Topics Initial Public Offering
News headline image
Renaissance Capital Bets Big on Tylenol and Kenvue (KVUE) By Purchasing Over 351,000 Shares ↗
Renaissance Capital Bets Big on Tylenol and Kenvue (KVUE) By Purchasing Over 351,000 Shares 
Via The Motley Fool
News headline image
Kenvue to Announce Third Quarter 2025 Results on November 6, 2025
From Kenvue
Via Business Wire
News headline image
3 Healthcare Stocks Paying the Highest Dividends of 2025 ↗
If you are looking for high yields in the healthcare sector, here are three choices. Make sure you understand the risks before you buy them. 
Via The Motley Fool
News headline image
Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever. ↗
Looking at high-yield healthcare stocks? These three stand out (but one has a slight skew to its story). 
Via The Motley Fool
Topics Government
News headline image
Renaissance Capital Sells Off 176K CRBG Shares Worth $6.3 Million ↗
Via The Motley Fool
Topics Regulatory Compliance Retirement
News headline image
These S&P500 stocks are gapping in today's session ↗
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Monday. Discover the gap up and gap down stocks in the S&P500 index. 
Via Chartmill
News headline image
3 Dividend Stocks With 5% (or Higher) Yields to Buy Hand Over Fist in October ↗
These three stocks have elevated yields and attractive dividend histories. 
Via The Motley Fool
News headline image
Meet the 5%-Yielding Dividend Stock That Could Soar in 2026 ↗
Kenvue could start to recover in 2026. 
Via The Motley Fool
News headline image
Johnson & Johnson's M&A Strategy Is the Real Story for Investors ↗
Johnson & Johnson’s rumored Protagonist buyout demonstrates its proven M&A strategy: divesting low-growth units to fund high-margin, innovative assets. 
Via MarketBeat
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday. 
Via Chartmill
News headline image
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. ↗
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.